Publication of Prospectus and Circular

RNS Number : 5502O

Phoenix Spree Deutschland Limited

09 February 2016

 

9 February 2016

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Phoenix Spree Deutschland Limited

(the "Company")

Publication of Prospectus and Circular

The prospectus of the Company dated 9 February 2016 (the "Prospectus") relating to the proposed Firm Placing, Offer for Subscription and Placing Programme (the "Proposals") announced earlier today has been approved by the Financial Conduct Authority and has been published. The Company has also sent a circular to its Shareholders today in relation to the Proposals (the "Circular").

Copies of the Prospectus and the Circular will be available for inspection during normal business hours on any weekday (public holidays excepted) at the registered office of the Company at 13-14 Esplanade, St Helier, Jersey JE1 1BD and by requesting a hard copy through Appleby Fund Administrators (Jersey) Limited on [phone]. Copies will also be available on the Company's website www.phoenixspree.com and will shortly be submitted to the National Storage Mechanism which can be accessed at http://www.morningstar.co.uk/uk/NSM.

For further information please contact:

PMM Partners UK Limited (Property Advisor)                [phone]

Mike Hilton

Matthew Northover

Paul Ruddle

Stuart Young

Liberum Capital Limited (Sponsor and Bookrunner)    [phone]

Shane Le Prevost

Richard Crawley

Christopher Britton

Jill Li

Bell Pottinger (Financial Public Relations)                       [phone]

Nick Lambert

Victoria Geoghegan

Elizabeth Snow

IMPORTANT INFORMATION

Terms defined in the Prospectus have the same meaning when used in this announcement, unless the context requires otherwise.

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and for no-one else in connection with any Admission and the Issues and the other transactions and arrangements referred to in this announcement and is not acting for, nor will it be responsible to any other person (whether or not a recipient of this announcement) in connection with, any Admission and the Issues including for providing the protections afforded to clients of Liberum or for providing advice in connection with any Admission, the Issues, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement. Liberum is not responsible for the contents of this announcement. Liberum has not authorised the contents of, or any part of, this announcement and no liability whatsoever is accepted by Liberum nor does it make any representation or warranty, express or implied, for the accuracy of any information or opinion contained in this announcement or for the omission of any information. Liberum disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement. This does not exclude or limit any responsibilities which Liberum may have under FSMA or the regulatory regime established thereunder.

The distribution of this announcement and other documents and/or information in connection with any Admission and the Issues in other jurisdictions may be restricted by law and therefore neither this announcement nor any other documents and/or information in connection with any Admission and the Issues may be published, distributed or transmitted by any means or media directly or indirectly, in whole or in part in or into any jurisdiction except under circumstances that will result in compliance with any applicable laws and regulations. Persons into whose possession any document and/or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions. This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer would be unlawful. In particular, this announcement does not constitute an offer to buy securities, and it is not for distribution, directly or indirectly, in or into the United States of America, Canada, Australia, the Republic of South Africa, or Japan.

The information contained in this announcement does not constitute an offering of securities for sale in the United States. The Shares have not been, and will not be, registered under the United States Securities Act 1933 (as amended) nor under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States of America or of any province or territory of Canada, Australia, the Republic of South Africa or Japan, nor in any country or territory where to do so may contravene local securities laws or regulations and will not be made to any national, resident or citizen of the United States of America, Canada, Australia, the Republic of South Africa or Japan. In addition, the Company has not been, and will not be, registered under the United States Investment Company 1940 (as amended).

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

END

 

 

PDIUGUWUPUPQGCB